No connection

Search Results

LMND

BEARISH
$65.77 Live
Lemonade, Inc. · NYSE
Target $65.11 (-1.0%)
$27.63 52W Range $99.9

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 29, 2026
Market cap
$5.05B
P/E
N/A
ROE
-29.4%
Profit margin
-22.4%
Debt/Equity
0.34
Dividend yield
N/A

AI Analysis

AI-powered fundamental assessment

Confidence
85%
Lemonade exhibits critical financial weakness with a Piotroski F-Score of 1/9, indicating severe instability in fundamental health. While the company demonstrates impressive top-line revenue growth of 53.5%, it remains deeply unprofitable with a negative ROE of -29.37% and a negative profit margin. Insider sentiment is strongly bearish, characterized by significant selling from the CEO and CFO with zero buying activity. The current valuation represents a massive premium over book value (P/B 9.36), making the stock a high-risk speculative play despite recent price momentum.

Key Strengths

Exceptional YoY revenue growth of 53.50%
Consistent track record of beating earnings estimates (3/4 last 4 quarters)
Relatively low Debt/Equity ratio of 0.34
Strong 1-year price performance (+122.8%)
High gross margins (52.98%) indicating a scalable core product

Key Risks

Severe fundamental instability as evidenced by a Piotroski F-Score of 1/9
Persistent net losses and negative ROE (-29.37%)
Aggressive insider selling totaling $22.39M with no offsetting buys
Extremely high valuation multiples (P/B 9.36, P/S 6.85)
Tight liquidity position with a Current Ratio of 1.00 and Quick Ratio of 0.71
AI Fair Value Estimate
Based on comprehensive analysis
$65.11
-1.0% below current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
31
Weak
Value
15
Future
85
Past
45
Health
10
Dividend
0
AI Verdict
Speculative Growth
Key drivers: Hyper-growth revenue, Critical financial health failure, Bearish insider activity
Confidence
90%
Value
15/100

Graham Number and Intrinsic Value are N/A due to lack of positive earnings.

Positives
No standout positives identified.
Watchpoints
  • P/B of 9.36 is excessive for insurance
  • Negative Forward P/E
  • P/S of 6.85 is high for the sector
Future
85/100

Growth rates are the primary driver of the current stock price.

Positives
  • 53.5% YoY Revenue Growth
  • 53.29% Q/Q Revenue Growth
  • Improving EPS surprises
Watchpoints
  • Path to profitability remains unclear
Past
45/100

Recent momentum masks long-term capital erosion.

Positives
  • Strong 1Y and 3Y price recovery
Watchpoints
  • 5Y change is still negative (-28.9%)
  • Long history of negative EPS
Health
10/100

Piotroski score indicates the company is in the weakest health tier.

Positives
  • Low Debt/Equity
Watchpoints
  • Piotroski F-Score 1/9
  • Negative ROA and ROE
  • Quick Ratio below 1.0
Dividend
0/100

Company is in a growth/loss phase; dividends are not applicable.

Positives
No standout positives identified.
Watchpoints
  • No dividend paid
  • No history of payouts

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$65.77
Analyst Target
$65.11
Upside/Downside
-1.0%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for LMND and closest competitors.

Updated 2026-04-28
LMN
Lemonade, Inc.
Primary
5Y
-28.9%
3Y
+506.7%
1Y
+122.8%
6M
+14.8%
1M
+12.0%
1W
-0.4%
IFS
Intercorp Financial Services Inc.
Peer
5Y
+124.9%
3Y
+126.2%
1Y
+39.4%
6M
+12.6%
1M
-1.6%
1W
-4.4%
HLN
Hamilton Lane Incorporated
Peer
5Y
+7.1%
3Y
+35.3%
1Y
-32.0%
6M
-21.2%
1M
-5.5%
1W
-2.0%
AX
Axos Financial, Inc.
Peer
5Y
+123.1%
3Y
+117.6%
1Y
+29.3%
6M
+8.3%
1M
+3.2%
1W
-2.9%
ASB
Associated Banc-Corp
Peer
5Y
+58.3%
3Y
+79.1%
1Y
+38.4%
6M
+12.5%
1M
+12.5%
1W
+0.9%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
N/A
Forward P/E
-182.69
PEG Ratio
N/A
P/B Ratio
9.36
P/S Ratio
6.85
EV/Revenue
6.51
EV/EBITDA
-39.56
Market Cap
$5.05B

Profitability

Profit margins and return metrics

Profit Margin -22.43%
Operating Margin -3.5%
Gross Margin 52.98%
ROE -29.37%
ROA -4.53%

Growth

Revenue and earnings growth rates

Revenue Growth +53.5%
Earnings Growth N/A
Q/Q Revenue Growth +53.29%
Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
0.34
Low debt
Current Ratio
1.0
Weak
Quick Ratio
0.71
Poor
Cash/Share
$5.22

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q4 2025

Revenue
$0.2B
Net Margin
-9.5%
Total Assets
$1.9B
Liabilities
$1.4B
Equity
$0.5B
Debt/Equity
2.61x
Operating CF
$0.0B
CapEx
$-0.0B
Free Cash Flow
$0.0B
FCF Yield
85%

Quarterly Earnings History

EPS performance vs analyst estimates

2026-04-29
$N/A
2026-02-19
$-0.29
+32.6% surprise
2025-11-05
$-0.55
+22.6% surprise
2025-08-05
$-0.76
+0.2% surprise

Financial Services Sector Comparison

Comparing LMND against 864 companies in the Financial Services sector (145 bullish, 368 neutral, 351 bearish)
Return on Equity (ROE)
-29.37%
This Stock
vs
-0.39%
Sector Avg
+7489.5% (Excellent)
Profit Margin
-22.43%
This Stock
vs
93.92%
Sector Avg
-123.9% (Weaker)
Debt to Equity
0.34
This Stock
vs
1.35
Sector Avg
-74.8% (Less Debt)
Revenue Growth
53.5%
This Stock
vs
36.33%
Sector Avg
+47.3% (Fast Growth)
Current Ratio
1.0
This Stock
vs
3.06
Sector Avg
-67.3% (Weaker)

Similar Companies

Peer comparison within the same industry

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

SCHREIBER DANIEL A
Chief Executive Officer
Stock Award
2026-03-18
1,000,000 shares
WININGER SHAI
President
Stock Award
2026-03-18
1,000,000 shares
ANGELIDIS SMITH MARIA
Director
Stock Award
2026-03-10
8,740 shares · $485,478
ANGELIDIS SMITH MARIA
Director
Buy
2026-03-10
8,740 shares · $485,478
ECKSTEIN ADINA
Chief Operating Officer
Stock Award
2026-03-06
145,112 shares
PROSOR MAYA
Officer
Stock Award
2026-03-06
181,389 shares
PETERS JOHN SHELDON
Officer
Sell
2026-03-04
5,344 shares · $276,340
BIXBY TIMOTHY E
Chief Financial Officer
Sell
2026-03-03
2,135 shares · $107,006
PROSOR MAYA
Officer
Sell
2026-03-03
223 shares · $11,177
PETERS JOHN SHELDON
Officer
Option Exercise
2026-02-12
11,845 shares · $137,520
SCHREIBER DANIEL A
Chief Executive Officer
Sell
2026-01-23
9,108 shares · $902,056
SCHREIBER DANIEL A
Chief Executive Officer
Sell
2026-01-22
126,625 shares · $11,996,452
PETERS JOHN SHELDON
Officer
Sell
2026-01-22
9,000 shares · $810,000
PETERS JOHN SHELDON
Officer
Option Exercise
2026-01-08
18,457 shares · $97,084
PETERS JOHN SHELDON
Officer
Sell
2026-01-06
10,000 shares · $800,000
Insider transactions can signal confidence or concerns about company prospects

SEC Filings

Recent regulatory filings from the SEC EDGAR database

DEF 14A
DEF 14A
2026-04-22

Lemonade Inc. (LMND) filed a definitive proxy statement on April 22, 2026, providing shareholders with necessary information and voting materials for its annual meeting.

10-K
10-K
2026-02-25

Lemonade filed its annual 10-K report on February 25, 2026. The provided excerpts do not contain specific financial metrics or detailed risk factors, as only the section headers were included.

8-K
8-K
2026-02-19

Lemonade, Inc. filed an 8-K likely reporting its fourth quarter and full-year financial results for 2025.

8-K
8-K
2026-01-27

Lemonade, Inc. filed an 8-K on January 27, 2026, likely to announce its fourth-quarter and full-year financial results.

10-Q
10-Q
2025-11-05

Lemonade Inc. filed its 10-Q quarterly report on November 5, 2025. The filing includes a dedicated section for risk factors under Item 1A, although specific financial highlights and detailed risk descriptions were not provided in the available excerpts.

8-K
8-K
2025-11-05

Lemonade, Inc. filed an 8-K on November 5, 2025, likely to announce its third-quarter 2025 financial results.

8-K
8-K
2025-10-15

Lemonade, Inc. announced its third-quarter financial results for 2025.

8-K
8-K
2025-10-06

Lemonade, Inc. filed an 8-K likely announcing its third-quarter financial results for 2025.

10-Q
10-Q
2025-08-05

Lemonade filed its quarterly 10-Q report on August 5, 2025. The filing includes a section on risk factors under Item 1A, although specific financial highlights and detailed risk descriptions were not provided in the available excerpt.

8-K
8-K
2025-08-05

Lemonade, Inc. filed an 8-K to report its second-quarter financial results for 2025.

8-K
8-K
2025-07-02
8-K
8-K
2025-06-09
8-K
8-K
2025-05-06
10-Q
10-Q
2025-05-06
DEF 14A
DEF 14A
2025-04-23
Data sourced from SEC EDGAR. AI summaries generated automatically.

Wall Street Analysts

Professional analyst ratings and price targets

Consensus
HOLD
9 analysts
Morgan Stanley
2026-03-17
up
Equal-Weight Overweight
Keefe, Bruyette & Woods
2026-02-24
Maintains
Underperform Underperform
Cantor Fitzgerald
2026-01-14
Maintains
Overweight Overweight
Truist Securities
2026-01-06
init
Buy
Keefe, Bruyette & Woods
2025-11-25
Maintains
Underperform Underperform
Citizens
2025-11-24
Maintains
Market Outperform Market Outperform
Morgan Stanley
2025-11-17
Maintains
Underweight Underweight
Morgan Stanley
2025-11-10
Maintains
Underweight Underweight

Past News Coverage

Recent headlines mentioning LMND from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI Chat
Markets
Profile